Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report
Authors:
- Rick R. van RijnRRRick R. van Rijn
- Henk van Den BergHBHenk van Den Berg
- Hans P. van Den AkkerHAHans P. van Den Akker
- 1 January 2009
- journal article
- case report
- Published by Elsevier in British Journal of Oral and Maxillofacial Surgery
- Vol. 47 (1) , 59-61
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Long-term imatinib therapy promotes bone formation in CML patientsBlood, 2008
- Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy optionsOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2007
- Giant cell granuloma of the jawbones – a proliferative vascular lesion? Immunohistochemical study with vascular endothelial growth factor and basic fibroblast growth factorJournal of Oral Pathology & Medicine, 2006
- Limited regression of central giant cell granuloma by interferon alpha after failed calcitonin therapy: a report of 2 casesInternational Journal of Oral and Maxillofacial Surgery, 2006
- Imatinib as a potential antiresorptive therapy for bone diseaseBlood, 2006
- Clinical features of hereditary progressive arthro-ophthalmopathy (Stickler syndrome): A surveyGenetics in Medicine, 2001
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996